Home » Topics » Regulatory

Regulatory
RSS

NDA submitted for Eligard 30 mg for advanced prostate cancer

April 18, 2002

Arcoxia granted major approval for relief of arthritis and pain

April 17, 2002

Glivec approved in Switzerland for GISTs

April 17, 2002

FDA grants priority review to Arimidex in early breast cancer

April 17, 2002

Committee recommends approval of Cozaar to delay renal disease in type 2 diabetics

April 16, 2002

Vioxx labeling changes and new indication

April 16, 2002

Sprinkle administration approved for ADHD treatment

April 16, 2002

E.U. approval for Dynastat in postoperative pain

April 12, 2002

E.U. submission for Arimidex in early-stage breast cancer in postmenopausal women

April 11, 2002

Priority review granted for pediatric labeling of Prevacid

April 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...